4.6 Article

Model-driven discovery of synergistic inhibitors against E-coli and S-enterica serovar Typhimurium targeting a novel synthetic lethal pair, aldA and prpC

Journal

FRONTIERS IN MICROBIOLOGY
Volume 6, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2015.00958

Keywords

synthetic lethality; antibiotic development; drug discovery; systems biology; metabolic reconstruction; bacterial metabolism; model-based drug target discovery; pathway gap filling

Categories

Funding

  1. NIH/NIGMS [GM098105]
  2. [GM057089]
  3. NNF Center for Biosustainability [New Bioactive Compounds] Funding Source: researchfish
  4. Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish

Ask authors/readers for more resources

Mathematical models of biochemical networks form a cornerstone of bacterial systems biology. Inconsistencies between simulation output and experimental data point to gaps in knowledge about the fundamental biology of the organism. One such inconsistency centers on the gene aldA in Escherichia colt: it is essential in a computational model of E. coli metabolism, but experimentally it is not. Here, we reconcile this disparity by providing evidence that aldA and prpC form a synthetic lethal pair, as the double knockout could only be created through complementation with a plasmid-borne copy of aldA. Moreover, virtual and biological screening against the two proteins led to a set of compounds that inhibited the growth of E. colt and Salmonella enterica serovar Typhimurium synergistically at 100-200 mu M individual concentrations. These results highlight the power of metabolic models to drive basic biological discovery and their potential use to discover new combination antibiotics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available